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Latent virus reactivation was measured in 17 astronauts (16 male and 1 female) before, during, and after 
short-duration Space Shuttle missions.  Blood, urine, and saliva samples were collected 2-4 months before 
launch, 10 days before launch (L-10), 2-3 hours after landing (R+0), 3 days after landing (R+14), and 120 
days after landing (R+120). Epstein-Barr virus (EBV) DNA was measured in these samples by quantitative 
polymerase chain reaction. Varicella-zoster virus (VZV) DNA was measured in the 381 saliva samples and 
cytomegalovirus (CMV) DNA in the 66 urine samples collected from these subjects.  Fourteen astronauts 
shed EBV DNA in 21% of their saliva samples before, during, and after flight, and 7 astronauts shed VZV 
in 7.4% of their samples during and after flight.  It was interesting that shedding of both EBV and VZV 
increased during the flight phase relative to before or after flight. In the case of CMV, 32% of urine 
samples from 8 subjects contained DNA of this virus. In normal healthy control subjects, EBV shedding 
was found in 3% and VZV and CMV were found in less than 1% of the samples.  The circadian rhythm of 
salivary cortisol measured before, during, and after space flight did not show any significant difference 
between flight phases. These data show that increased reactivation of latent herpes viruses may be 
associated with decreased immune system function, which has been reported in earlier studies as well as in 
these same subjects (data not reported here). 
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